- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.50 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x ZN: ZINC ION(Non-covalent)
- 2 x IW8: 1-[(1-acetyl-5-bromo-1H-indol-6-yl)sulfonyl]-N-ethyl-N-(3-methylphenyl)piperidine-4-carboxamide(Non-covalent)
IW8.2: 22 residues within 4Å:- Chain A: H.105, G.106, S.107, P.108, F.109, A.112, I.113, K.116, G.117, F.118, D.119, H.122, A.123, G.132, I.133, Y.134, Y.145, G.148, I.149
- Chain B: T.157, H.158, I.165
15 PLIP interactions:14 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:F.109, A:F.109, A:F.109, A:A.112, A:H.122, A:Y.134, A:Y.145, A:I.149, A:I.149, B:I.165
- Hydrogen bonds: A:D.119, A:Y.134
- pi-Stacking: A:H.122, A:H.122
- Halogen bonds: A:G.117
IW8.10: 22 residues within 4Å:- Chain A: T.157, H.158, I.165
- Chain B: H.105, G.106, S.107, P.108, F.109, A.112, I.113, K.116, G.117, F.118, D.119, H.122, A.123, G.132, I.133, Y.134, Y.145, G.148, I.149
15 PLIP interactions:1 interactions with chain A, 14 interactions with chain B- Hydrophobic interactions: A:I.165, B:F.109, B:F.109, B:F.109, B:A.112, B:H.122, B:Y.134, B:Y.145, B:I.149, B:I.149
- Hydrogen bonds: B:D.119, B:Y.134
- pi-Stacking: B:H.122, B:H.122
- Halogen bonds: B:G.117
- 12 x CL: CHLORIDE ION(Non-functional Binders)
CL.3: 5 residues within 4Å:- Chain A: V.75, N.76, K.77, R.80, Y.222
Ligand excluded by PLIPCL.4: 4 residues within 4Å:- Chain A: H.53, R.54, A.209, Y.210
Ligand excluded by PLIPCL.5: 5 residues within 4Å:- Chain A: P.108, F.109, N.111, A.112
- Chain B: H.167
Ligand excluded by PLIPCL.6: 6 residues within 4Å:- Chain A: A.112, H.115, K.116
- Chain B: I.69, R.70, H.167
Ligand excluded by PLIPCL.7: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.8: 3 residues within 4Å:- Chain A: H.97, H.98, N.99
Ligand excluded by PLIPCL.11: 5 residues within 4Å:- Chain B: V.75, N.76, K.77, R.80, Y.222
Ligand excluded by PLIPCL.12: 4 residues within 4Å:- Chain B: H.53, R.54, A.209, Y.210
Ligand excluded by PLIPCL.13: 5 residues within 4Å:- Chain A: H.167
- Chain B: P.108, F.109, N.111, A.112
Ligand excluded by PLIPCL.14: 6 residues within 4Å:- Chain A: I.69, R.70, H.167
- Chain B: A.112, H.115, K.116
Ligand excluded by PLIPCL.15: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.16: 3 residues within 4Å:- Chain B: H.97, H.98, N.99
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kulak, O. et al., Disruption of Wnt/ beta-Catenin Signaling and Telomeric Shortening Are Inextricable Consequences of Tankyrase Inhibition in Human Cells. Mol.Cell.Biol. (2015)
- Release Date
- 2015-05-20
- Peptides
- Tankyrase-1: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
C
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.50 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x ZN: ZINC ION(Non-covalent)
- 2 x IW8: 1-[(1-acetyl-5-bromo-1H-indol-6-yl)sulfonyl]-N-ethyl-N-(3-methylphenyl)piperidine-4-carboxamide(Non-covalent)
- 12 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kulak, O. et al., Disruption of Wnt/ beta-Catenin Signaling and Telomeric Shortening Are Inextricable Consequences of Tankyrase Inhibition in Human Cells. Mol.Cell.Biol. (2015)
- Release Date
- 2015-05-20
- Peptides
- Tankyrase-1: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
C